Pfizer Inc. (NYSE: PFE) will host its virtual Investor Day today
and tomorrow: Monday, September 14, 2020 from 1:00 p.m. EDT to 3:45
p.m. EDT and Tuesday, September 15, 2020 from 10:00 a.m. EDT to
1:30 p.m. EDT. Pfizer business executives and scientific leadership
will provide updates on the company’s progress in advancing its
R&D pipeline, specifically on product candidates with
blockbuster potential that are expected to launch by 2025.
The agenda for Pfizer’s Investor Day is as follows:
DAY 1
Monday September 14, 2020 | 1:00 p.m. -
3:45 p.m. ET
DAY 2
Tuesday September 15, 2020 | 10:00 a.m. -
1:30 p.m. ET
1:00 p.m.
Welcome & Introduction to Day
1
Speaker: Chuck Triano
10:00 a.m.
Welcome & Introduction to Day
2
Speaker: Chuck Triano
1:05 p.m.
Executive Leadership Team Plenary
Session
- Pfizer “Big Picture” Speaker: Albert Bourla
- R&D Turnaround Story Speaker: Mikael Dolsten
- Productivity of Clinical Change Speaker: Rod
MacKenzie
- Pfizer Biopharmaceuticals Group Core Therapeutic Area
Overview Speaker: Angela Hwang
10:05 a.m.
Inflammation & Immunology Triad
Presentation and Q&A
Speakers: Richard Blackburn, Michael
Corbo, Michael Vincent & Tamas Koncz
10:50 a.m.
Rare Disease Triad Presentation and
Q&A
Speakers: Suneet Varma, Brenda Cooperstone
& Seng Cheng
10 Minute Break
10 Minute Break
2:15 p.m.
Internal Medicine Triad Presentation
and Q&A
Speakers: Michael Gladstone, James Rusnak
& Morris Birnbaum
11:45 a.m.
Oncology Triad Presentation and
Q&A
Speakers: Andy Schmeltz, Chris Boshoff,
Jeff Settleman & Nicholas Saccomano
3:00 p.m.
Vaccines Tetrad Presentation and
Q&A
Speakers: Nanette Cocero, Luis Jodar,
Kathrin Jansen & William Gruber
5 Minute Break
12:35 p.m.
Updates on COVID-19 Programs and
Q&A
Speakers: Mikael Dolsten, Kathrin Jansen
& Angela Hwang
1:20 p.m.
Closing Remarks
Speaker: Albert Bourla
To access the live webcast, including audio, video and
presentation slides, visit our web site at
www.pfizer.com/investors. The webcast can also be accessed directly
at www.PfizerInvestorDay.virtualeventsite.com. Participants are
advised to register in advance.
Investors and analysts will also have an opportunity to ask
questions in live Q&A sessions with speakers. Those
participants who would like to ask a question can dial either (833)
711-4985 in the United States and Canada or (916) 637-9673 outside
of the United States and Canada. The password is “Pfizer2020”.
Members of the media are invited to monitor the call by dialing
(833) 711-4985 in the United States and Canada or (916) 637-9673
outside of the United States and Canada with the password
“Pfizer2020”. Journalists who wish to ask questions are requested
to contact a member of Pfizer’s Media Relations team.
Interested parties unable to watch the live webcast will be able
to view and listen to an archived copy of the webcast, which will
be available on www.pfizer.com/investors following the conclusion
of the event.
About Pfizer: Breakthroughs That Change Patients’
Lives
At Pfizer, we apply science and our global resources to bring
therapies to people that extend and significantly improve their
lives. We strive to set the standard for quality, safety and value
in the discovery, development and manufacture of health care
products, including innovative medicines and vaccines. Every day,
Pfizer colleagues work across developed and emerging markets to
advance wellness, prevention, treatments and cures that challenge
the most feared diseases of our time. Consistent with our
responsibility as one of the world's premier innovative
biopharmaceutical companies, we collaborate with health care
providers, governments and local communities to support and expand
access to reliable, affordable health care around the world. For
more than 150 years, we have worked to make a difference for all
who rely on us. We routinely post information that may be important
to investors on our website at www.Pfizer.com. In addition, to
learn more, please visit us on www.Pfizer.com and follow us on
Twitter at @Pfizer and @Pfizer News, LinkedIn, YouTube and like us
on Facebook at Facebook.com/Pfizer.
Disclosure Notice: The webcast may include
forward-looking statements about, among other things, our
anticipated operating and financial performance, business plans and
prospects, expectations for our product pipeline, in-line products
and product candidates, including anticipated regulatory
submissions, data read-outs, study starts, approvals, revenue
contribution, growth, performance, timing of exclusivity and
potential benefits, manufacturing and product supply, our efforts
to respond to COVID-19, including our investigational vaccine
candidate against SARS-CoV-2 and our investigational protease
inhibitor, our expectations regarding the impact of COVID-19, our
ability to successfully capitalize on growth opportunities and
prospects, plans for and prospects of our acquisitions and other
business development activities, including our proposed transaction
with Mylan N.V. (Mylan) to combine Upjohn and Mylan to create a new
global pharmaceutical company and plans relating to share
repurchases and dividends, among other things, that are subject to
substantial risks and uncertainties that could cause actual results
to differ materially from those expressed or implied by such
statements. A description of these risks and uncertainties can be
found in Pfizer’s Annual Report on Form 10-K for the fiscal year
ended December 31, 2019 and in its subsequent reports on Form 10-Q,
including in the sections thereof captioned “Risk Factors” and
“Forward-Looking Information and Factors That May Affect Future
Results”, as well as in its subsequent reports on Form 8-K, all of
which are filed with the U.S. Securities and Exchange Commission
and available at www.sec.gov and www.pfizer.com.
The forward-looking statements in the webcast speak only as of
the original date of the webcast. Pfizer assumes no obligation to
update forward-looking statements contained in the webcast as the
result of new information or future events or developments.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200914005083/en/
Media Relations:
Amy Rose +1 (646) 592-3157 Amy.Rose@Pfizer.com
Investor Relations:
Ryan Crowe +1 (212) 733-8160 Ryan.Crowe@Pfizer.com
Pfizer (NYSE:PFE)
Historical Stock Chart
From Mar 2024 to Apr 2024
Pfizer (NYSE:PFE)
Historical Stock Chart
From Apr 2023 to Apr 2024